Published: May 8, 2026
Written by Klarity Editorial Team
Published: May 8, 2026

If you’re experiencing fatigue, low libido, mood changes, or other symptoms of low testosterone, you might wonder: Can I get diagnosed and treated through telehealth? The short answer is yes—in most cases, you can receive legitimate low testosterone treatment entirely online in 2025, including prescriptions for medications like Clomid (clomiphene citrate).
But with evolving federal rules, varying state laws, and growing scrutiny of telehealth prescribing practices, it’s important to understand what’s legal, what’s safe, and what to expect. This guide breaks down everything you need to know about getting low T treatment via telehealth, from diagnosis to prescriptions to follow-up care.
Low testosterone (hypogonadism) affects millions of American men, causing symptoms like decreased energy, reduced muscle mass, weight gain, depression, and diminished sexual function. According to the American Urological Association (AUA), diagnosis requires two separate morning testosterone readings below 300 ng/dL, combined with consistent symptoms.
The COVID-19 pandemic accelerated telehealth adoption across healthcare, including men’s health. What once required multiple in-person doctor visits—initial consultation, lab orders, follow-up for results, and prescription—can now often be completed remotely through video visits and at-home lab kits.
This convenience has opened access for men in rural areas, those with busy schedules, or anyone uncomfortable discussing sensitive health issues in person. However, it’s also created a landscape where patients need to distinguish between legitimate medical care and ‘pill mills’ operating online.
Good news: Prescribing medications for low testosterone via telehealth is federally legal through at least December 31, 2025. Here’s why:
The Drug Enforcement Administration (DEA) has extended COVID-era flexibilities for the third time, allowing healthcare providers to prescribe controlled substances—including testosterone (a Schedule III controlled drug)—via telemedicine without an initial in-person examination. This extension was announced in November 2024 and runs through the end of 2025.
For non-controlled medications like Clomid (clomiphene citrate), there has never been a federal requirement for an in-person visit. The Ryan Haight Act, which normally requires in-person exams before prescribing controlled substances online, only applies to controlled drugs—meaning medications like Clomid can be prescribed via telehealth without restriction under federal law.
The DEA has been working on permanent telemedicine prescribing regulations, including a proposed ‘special registration’ system for providers. However, implementation has been repeatedly delayed due to stakeholder feedback. Patients and providers should monitor for potential rule changes in 2026, though many experts expect another extension given the strong demand for telehealth access.
Bottom line: If you’re considering telehealth low T treatment in 2025, federal law permits it. Just be aware that rules may evolve in the future.
While federal law sets the baseline, state regulations vary significantly. Here’s what matters most for the seven priority states we researched:
Texas, California, Florida, Delaware: These states allow telehealth prescribing for low testosterone treatment without requiring an initial in-person visit for non-controlled medications. California recently moved to allow even asynchronous (questionnaire-based) evaluations for certain prescriptions, though a ‘good faith exam’ via video is still the standard.
New Hampshire: Made major changes in 2025, removing previous in-person requirements for controlled substance prescribing via telehealth. Providers can now prescribe testosterone remotely as long as patients have an in-person evaluation at least once every 12 months (which can be with any licensed prescriber, not necessarily the telehealth doctor).
New York: Allows telehealth prescribing but has adopted state rules mirroring the DEA’s proposed in-person requirement for controlled substances. However, these rules are currently suspended while the federal waiver remains active through 2025.
Alabama: Requires an in-person visit within 12 months if you receive telehealth treatment for the same condition more than four times in a year. This can be done with a local collaborating provider, not necessarily your telehealth physician.
Georgia: Has the strictest rules among priority states. Georgia requires an initial in-person examination before establishing a telehealth relationship, with attempts at an annual in-person follow-up. Additionally, nurse practitioners in Georgia cannot prescribe Schedule II controlled substances (though this doesn’t affect Clomid prescribing).
Regardless of where you live, your telehealth provider must be licensed in your state. A doctor licensed only in California cannot legally treat patients in Texas via telehealth. Reputable platforms like Klarity Health ensure all providers are properly licensed in the states where they practice, eliminating this compliance risk for patients.
A legitimate telehealth evaluation for low testosterone should include:
Avoid telehealth services that:
Recent federal enforcement actions have targeted fraudulent telehealth operations. In November 2025, the founder of a telehealth ADHD startup was convicted for prescribing 40 million Adderall pills without proper examinations—a landmark case signaling increased scrutiny of online prescribing practices.
Clomid is a non-controlled medication FDA-approved for female fertility treatment but widely used off-label for male hypogonadism. It works by blocking estrogen receptors in the brain, which triggers increased production of hormones that stimulate natural testosterone production.
Advantages:
Considerations:
Direct testosterone (injections, gels, patches) is a Schedule III controlled substance, making it subject to DEA telemedicine rules—though currently permitted via telehealth through the end of 2025.
Advantages:
Considerations:
Your telehealth provider will recommend treatment based on:
You’ll meet with a licensed physician or nurse practitioner via video call to discuss symptoms, medical history, and treatment goals. The provider will explain diagnostic requirements and may order initial labs if you haven’t had recent testing.
If you haven’t had recent testosterone tests, you’ll need blood work. Many telehealth platforms partner with national lab networks (Quest, LabCorp) or offer at-home testing kits. Two morning samples are standard, taken on separate days to confirm diagnosis.
Once labs confirm low testosterone, your provider will review results with you, discuss treatment options, and—if appropriate—send a prescription electronically to your chosen pharmacy. For Clomid, this is straightforward in all states. For testosterone, the provider must comply with state prescription monitoring requirements.
Responsible low T treatment requires follow-up:
Telehealth makes follow-ups more convenient—no need to take time off work for quick check-ins. However, some states (like Alabama and Georgia) may require periodic in-person visits for ongoing treatment.
Whether a nurse practitioner (NP) or physician assistant (PA) can prescribe low testosterone treatment depends heavily on your state:
Full Practice Authority States (NPs can prescribe independently):
Collaborative Practice States (NPs/PAs need physician agreements):
Restricted States:
Many telehealth platforms employ both physicians and advanced practice providers (NPs/PAs) to expand availability and keep costs down. This is perfectly appropriate—NPs and PAs receive extensive training in hormone therapy and men’s health.
However, ensure your provider has the appropriate authority in your state. Platforms like Klarity Health credential all providers carefully and match you with practitioners authorized to prescribe in your specific location.
If you receive testosterone (a controlled substance), your provider must check your state’s prescription monitoring database. These checks prevent ‘doctor shopping’ and identify potential drug interactions or misuse patterns.
State requirements vary:
For Clomid (non-controlled), PMP checks aren’t required, though responsible providers still review medication histories.
Legitimate telehealth low T treatment includes:
Telehealth has limitations. Seek in-person care if:
Initial consultations typically range from $50-200 depending on the platform and provider type. Follow-up visits are often less expensive ($40-100).
Platforms like Klarity Health offer transparent pricing upfront and accept both insurance and cash pay, giving you flexibility based on your coverage.
Many insurance plans now cover telehealth visits at the same rate as in-person care. However, coverage for low testosterone treatment itself varies:
Always verify coverage before starting treatment. Cash-pay options provide an alternative if insurance denies coverage.
Getting testosterone treatment shouldn’t require navigating complex regulations and availability challenges on your own. Klarity Health makes the process straightforward:
Our platform combines convenience with clinical rigor—lab-confirmed diagnosis, standard-of-care treatment protocols, and regular follow-up to optimize your health.
✅ Telehealth low testosterone treatment is legal through at least the end of 2025 under federal rules, with no in-person requirement for non-controlled medications like Clomid
✅ State rules vary: Most states allow fully remote treatment; a few (Georgia, Alabama) require periodic in-person visits
✅ Legitimate diagnosis requires lab confirmation: Two morning testosterone tests below 300 ng/dL plus documented symptoms
✅ Clomid is a viable telehealth option: Non-controlled, fertility-friendly medication widely used off-label for low testosterone
✅ Provider credentials matter: Ensure your telehealth provider is licensed in your state and has appropriate prescribing authority
✅ Ongoing monitoring is essential: Expect regular follow-ups, repeat labs, and symptom assessments—not one-time prescriptions
✅ Beware of illegitimate services: Avoid platforms that skip exams, don’t require labs, or promise ‘easy prescriptions’
✅ Rules may change after 2025: Stay informed about potential DEA telemedicine regulation updates
If you’re experiencing symptoms of low testosterone, telehealth offers a convenient, legitimate pathway to diagnosis and treatment—when done right. The key is choosing a reputable platform that prioritizes your safety and follows evidence-based protocols.
Ready to explore treatment options? Klarity Health connects you with experienced providers who understand men’s health and the nuances of telehealth prescribing. With transparent pricing, fast availability, and both insurance and cash-pay options, we make quality care accessible.
Don’t let low testosterone impact your quality of life. Schedule a consultation with Klarity Health today and take the first step toward feeling like yourself again—all from the comfort and privacy of home.
Can I get testosterone prescribed online without seeing a doctor in person?
Yes, through at least December 31, 2025, federal rules allow controlled substances like testosterone to be prescribed via telehealth without an initial in-person visit. However, your state may have additional requirements (a few states require periodic in-person follow-ups for ongoing treatment). Non-controlled medications like Clomid have no federal in-person requirements.
Is online low T treatment legitimate or just a scam?
Both legitimate services and scams exist. Legitimate telehealth platforms require comprehensive medical history, lab-confirmed diagnosis (two testosterone tests), live provider consultations, and ongoing monitoring. Red flags include: no required labs, questionnaire-only prescribing, shipping from overseas, or providers not licensed in your state.
What’s the difference between Clomid and testosterone injections for low T?
Clomid (clomiphene) is a non-controlled oral medication that stimulates your body’s natural testosterone production and preserves fertility. It’s used off-label for male low testosterone. Testosterone injections directly replace the hormone but suppress natural production and sperm count. Clomid is easier to prescribe via telehealth (no controlled substance restrictions) and better for men concerned about fertility.
Do I need to get blood work done before telehealth low T treatment?
Yes. Legitimate diagnosis requires lab confirmation—typically two morning testosterone readings below 300 ng/dL on separate days, plus documented symptoms. Your telehealth provider can order labs through partner facilities (Quest, LabCorp) or at-home testing kits. Treatment without lab confirmation is not medically appropriate.
Will my insurance cover telehealth low T treatment?
Many insurance plans cover telehealth visits at the same rate as in-person care. Coverage for low testosterone treatment itself varies by plan and whether you meet diagnostic criteria. Some plans may not cover off-label medication use (like Clomid for men). Platforms like Klarity Health accept both insurance and cash pay, giving you options if insurance denies coverage.
📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA and HHS Extend Telemedicine Flexibilities Through 2025 (November 15, 2024)
U.S. Drug Enforcement Administration official announcement
https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025
Telehealth and ‘In-Person’ Visits: Diverging State Requirements (August 15, 2025)
Sheppard Mullin Healthcare Law Blog (50-state survey)
https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/
DEA Signals Extension of Telemedicine Flexibilities into 2026 (November 19, 2025)
McDermott Will & Emery Legal Analysis
https://www.jdsupra.com/legalnews/dea-signals-extension-of-telemedicine-3341195/
Testosterone Deficiency: AUA Guideline (Reviewed 2024)
American Urological Association Clinical Guidelines
https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
COVID-era Telehealth Prescribing Extended Again Through 2025 (November 18, 2024)
Axios Healthcare News Report
https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall
DEA Rules Status: COVID-19 telehealth flexibilities for controlled substances extended through December 31, 2025 (third extension in November 2024). No new DEA final rule in effect yet; special registration system pending future implementation.
States Verified: Texas, California, Florida, New York, Georgia, Alabama, New Hampshire, and Delaware regulations confirmed current through November-December 2025 via state medical boards, legislative updates, and authoritative legal analyses.
⚠️ Flagged for follow-up: Monitor DEA for likely fourth extension into 2026 or implementation of special telemedicine registration requirements. Check state laws in 2026 for any newly effective telehealth or prescriptive authority changes.
Find the right provider for your needs — select your state to find expert care near you.